Scope of the Study
Pet is an animal kept primarily for a person's company or entertainment rather than as a working animal, livestock or a laboratory animal. Pet medications are used to manage, treat or cure the pet's medical conditions. Antibiotics, non-steroidal anti-inflammatories, opioid pain relievers, antiparasitics, chemotherapeutics and others.
The market study is being classified by Type (Antibiotics, Antimicrobials, Antiparasitics and Chemotherapeutics), by Application (Cat, Dog, Horse, Fish and Other) and major geographies with country level break-up.
Zoetis Inc. (United States), Merck & Co., Inc. (United States), Merial (France), Elanco Animal Health (United States), Bayer (Germany), C.H. Boehringer Sohn AG & Ko. KG (Germany), Novartis (Switzerland), Virbac (France), Vetoquinol (France) and Nexvet (Australia) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Kindred Biosciences (United States) and Entest Biomedical (United States).
AdvanceMarketAnalytics has segmented the market of Global Pet Medication market by Type, Application and Region.
On the basis of geography, the market of Pet Medication has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
- Increased Adoption of Pets
- Rising number of Pet Physicians
- Growing Awareness about Pet Health
- Growing Pet Pharmacies Worldwide
- Growing Number of E-Pharmacies
- Stringent Rules and Regulations
Market Leaders and their expansionary development strategies
In November 2018, Zoetis Inc. and Abaxis, Inc. has announced a definitive merger agreement pursuant to which Zoetis will acquire Abaxis, a leader in the development, manufacture and marketing of diagnostic instruments for veterinary point-of-care services. The acquisition is expected to enhance Zoetis’ presence in veterinary diagnostics, a category of the animal health industry with approximately 10% compound annual growth over the last three years
Key Target AudiencePet Medication Manufacturers, Raw Material Suppliers, Distributors, Research Professionals, Distributors and End-users
Customization in the Report Available:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase